BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Han Z, Shi L. Long non-coding RNA LUCAT1 modulates methotrexate resistance in osteosarcoma via miR-200c/ABCB1 axis. Biochemical and Biophysical Research Communications 2018;495:947-53. [DOI: 10.1016/j.bbrc.2017.11.121] [Cited by in Crossref: 65] [Cited by in F6Publishing: 66] [Article Influence: 16.3] [Reference Citation Analysis]
Number Citing Articles
1 Wang K, Yan L, Lu F. miR-363-3p Inhibits Osteosarcoma Cell Proliferation and Invasion via Targeting SOX4. Oncol Res 2019;27:157-63. [PMID: 29471893 DOI: 10.3727/096504018X15190861873459] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
2 Wang L, Tang D, Wu T, Sun F. ELF1-mediated LUCAT1 promotes choroidal melanoma by modulating RBX1 expression. Cancer Med 2020;9:2160-70. [PMID: 31968402 DOI: 10.1002/cam4.2859] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 4.5] [Reference Citation Analysis]
3 Yang L, Zhang L, Lu L, Wang Y. miR-214-3p Regulates Multi-Drug Resistance and Apoptosis in Retinoblastoma Cells by Targeting ABCB1 and XIAP. Onco Targets Ther 2020;13:803-11. [PMID: 32095078 DOI: 10.2147/OTT.S235862] [Cited by in Crossref: 9] [Cited by in F6Publishing: 2] [Article Influence: 4.5] [Reference Citation Analysis]
4 Nai Y, Pan C, Hu X, Ma Y. LncRNA LUCAT1 contributes to cell proliferation and migration in human pancreatic ductal adenocarcinoma via sponging miR-539. Cancer Med 2020;9:757-67. [PMID: 31789465 DOI: 10.1002/cam4.2724] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
5 Hu X, Wen Y, Tan LY, Wang J, Tang F, Wang YT, Zheng CX, Zhang YQ, Gong TJ, Min L. Exosomal Long Non-Coding RNA ANCR Mediates Drug Resistance in Osteosarcoma. Front Oncol 2021;11:735254. [PMID: 35096563 DOI: 10.3389/fonc.2021.735254] [Reference Citation Analysis]
6 Farzaneh M, Najafi S, Anbiyaee O, Azizidoost S, Khoshnam SE. LncRNA MALAT1-related signaling pathways in osteosarcoma. Clin Transl Oncol 2022. [PMID: 35790599 DOI: 10.1007/s12094-022-02876-x] [Reference Citation Analysis]
7 An Q, Zhou L, Xu N. Long noncoding RNA FOXD2-AS1 accelerates the gemcitabine-resistance of bladder cancer by sponging miR-143. Biomed Pharmacother. 2018;103:415-420. [PMID: 29674277 DOI: 10.1016/j.biopha.2018.03.138] [Cited by in Crossref: 37] [Cited by in F6Publishing: 42] [Article Influence: 9.3] [Reference Citation Analysis]
8 Cui H, Zhao J. LncRNA TMPO‐AS1 serves as a ceRNA to promote osteosarcoma tumorigenesis by regulating miR‐199a‐5p/WNT7B axis. J Cell Biochem 2020;121:2284-93. [DOI: 10.1002/jcb.29451] [Cited by in Crossref: 17] [Cited by in F6Publishing: 20] [Article Influence: 5.7] [Reference Citation Analysis]
9 Chen Y, Tergaonkar V. LncRNAs: Master Regulators in Disease and Cancer. Proc Singapore Natl Acad Sci 2020;14:79-89. [DOI: 10.1142/s2591722620400062] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Chen Y, Zhang K, Li Y, Guo R, Zhang K, Zhong G, He Q. Oestrogen-related receptor alpha mediates chemotherapy resistance of osteosarcoma cells via regulation of ABCB1. J Cell Mol Med 2019;23:2115-24. [PMID: 30609256 DOI: 10.1111/jcmm.14123] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
11 Qu Y, Tan HY, Chan YT, Jiang H, Wang N, Wang D. The functional role of long noncoding RNA in resistance to anticancer treatment. Ther Adv Med Oncol 2020;12:1758835920927850. [PMID: 32536982 DOI: 10.1177/1758835920927850] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
12 Cong M, Jing R. Long non-coding RNA TUSC7 suppresses osteosarcoma by targeting miR-211. Biosci Rep 2019;39:BSR20190291. [PMID: 31652435 DOI: 10.1042/BSR20190291] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
13 Žlajpah M, Urh K, Grosek J, Zidar N, Boštjančič E. Differential Expression of Decorin in Metastasising Colorectal Carcinoma Is Regulated by miR-200c and Long Non-Coding RNAs. Biomedicines 2022;10:142. [DOI: 10.3390/biomedicines10010142] [Reference Citation Analysis]
14 Bhattacharjee S, Li J, Dashwood RH. Emerging crosstalk between long non-coding RNAs and Nrf2 signaling. Cancer Letters 2020;490:154-64. [DOI: 10.1016/j.canlet.2020.07.011] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
15 Luzón-Toro B, Fernández RM, Martos-Martínez JM, Rubio-Manzanares-Dorado M, Antiñolo G, Borrego S. LncRNA LUCAT1 as a novel prognostic biomarker for patients with papillary thyroid cancer. Sci Rep 2019;9:14374. [PMID: 31591432 DOI: 10.1038/s41598-019-50913-7] [Cited by in Crossref: 21] [Cited by in F6Publishing: 24] [Article Influence: 7.0] [Reference Citation Analysis]
16 Zhang L, Liu S, Song L, Yao H. SP1-induced up-regulation of lncRNA LUCAT1 promotes proliferation, migration and invasion of cervical cancer by sponging miR-181a. Artificial Cells, Nanomedicine, and Biotechnology 2019;47:555-63. [DOI: 10.1080/21691401.2019.1575840] [Cited by in Crossref: 12] [Cited by in F6Publishing: 16] [Article Influence: 4.0] [Reference Citation Analysis]
17 Yu H, Xu Y, Zhang D, Liu G. Long noncoding RNA LUCAT1 promotes malignancy of ovarian cancer through regulation of miR-612/HOXA13 pathway. Biochemical and Biophysical Research Communications 2018;503:2095-100. [DOI: 10.1016/j.bbrc.2018.07.165] [Cited by in Crossref: 40] [Cited by in F6Publishing: 45] [Article Influence: 10.0] [Reference Citation Analysis]
18 Godel M, Morena D, Ananthanarayanan P, Buondonno I, Ferrero G, Hattinger CM, Di Nicolantonio F, Serra M, Taulli R, Cordero F, Riganti C, Kopecka J. Small Nucleolar RNAs Determine Resistance to Doxorubicin in Human Osteosarcoma. Int J Mol Sci 2020;21:E4500. [PMID: 32599901 DOI: 10.3390/ijms21124500] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
19 Liu Y, Cheng T, Du Y, Hu X, Xia W. LncRNA LUCAT1/miR-181a-5p axis promotes proliferation and invasion of breast cancer via targeting KLF6 and KLF15. BMC Mol Cell Biol 2020;21:69. [PMID: 32998707 DOI: 10.1186/s12860-020-00310-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
20 Malakoti F, Alemi F, Karimzadeh H, Asemi Z, Asadi M, Ghobadi H, Soleimanpour J, Yousefi B. Long noncoding RNA-miRNA-mRNA axes multiple roles in osteosarcoma. Gene Reports 2021;23:101090. [DOI: 10.1016/j.genrep.2021.101090] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
21 Lemos S, Sampaio-Marques B, Ludovico P, Gaivão I, Palmeira C, Martins G, Peixoto F, Pinto-Leite R, Oliveira P. Elucidating the mechanisms of action of parecoxib in the MG-63 osteosarcoma cell line. Anticancer Drugs 2020;31:507-17. [PMID: 31934887 DOI: 10.1097/CAD.0000000000000901] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
22 Xie Y, Wang M, Shao Y, Deng X, Chen Y. Long Non-coding RNA KCNQ1OT1 Contributes to Antiepileptic Drug Resistance Through the miR-138-5p/ABCB1 Axis in vitro. Front Neurosci 2019;13:1358. [PMID: 31920517 DOI: 10.3389/fnins.2019.01358] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
23 Xia Q, Zhang L, Yan H, Yu L, Shan W, Jiang H. LUCAT1 contributes to MYRF-dependent smooth muscle cell apoptosis and may facilitate aneurysm formation via the sequestration of miR-199a-5p. Cell Biol Int 2020;44:755-63. [PMID: 31769911 DOI: 10.1002/cbin.11270] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
24 Rahemi S, Nematollahi-Mahani SN, Rajaie A, Fallah H. Inhibitor of Interleukin-1 Receptor-associated Kinases 1/4, Can Increase the Sensitivity of Breast Cancer Cells to Methotrexate. Int J Mol Cell Med 2019;8:200-9. [PMID: 32489949 DOI: 10.22088/IJMCM.BUMS.8.3.200] [Reference Citation Analysis]
25 Prudowsky ZD, Yustein JT. Recent Insights into Therapy Resistance in Osteosarcoma. Cancers (Basel) 2020;13:E83. [PMID: 33396725 DOI: 10.3390/cancers13010083] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 7.0] [Reference Citation Analysis]
26 Corrà F, Agnoletto C, Minotti L, Baldassari F, Volinia S. The Network of Non-coding RNAs in Cancer Drug Resistance. Front Oncol 2018;8:327. [PMID: 30211115 DOI: 10.3389/fonc.2018.00327] [Cited by in Crossref: 54] [Cited by in F6Publishing: 52] [Article Influence: 13.5] [Reference Citation Analysis]
27 Zhang K, Wang Q, Zhong B, Gong Z. LUCAT1 as an oncogene in tongue squamous cell carcinoma by targeting miR-375 expression. J Cell Mol Med 2021;25:4543-50. [PMID: 33787082 DOI: 10.1111/jcmm.15982] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
28 Zhou Y, Song X, Li X, Li H, Peng Y. Serum LUCAT1 implicates the pathogenesis of muscle-invasive bladder cancer via targeting miR-199a-5p and miR-199b-5p. J Mol Histol 2020;51:583-91. [PMID: 32844284 DOI: 10.1007/s10735-020-09907-3] [Reference Citation Analysis]
29 Huan L, Guo T, Wu Y, Xu L, Huang S, Xu Y, Liang L, He X. Hypoxia induced LUCAT1/PTBP1 axis modulates cancer cell viability and chemotherapy response. Mol Cancer 2020;19:11. [PMID: 31964396 DOI: 10.1186/s12943-019-1122-z] [Cited by in Crossref: 20] [Cited by in F6Publishing: 23] [Article Influence: 10.0] [Reference Citation Analysis]
30 Wang X, Guo S, Zhao R, Liu Y, Yang G. STAT3-Activated Long Non-Coding RNA Lung Cancer Associated Transcript 1 Drives Cell Proliferation, Migration, and Invasion in Hepatoblastoma Through Regulation of the miR-301b/STAT3 Axis. Human Gene Therapy 2019;30:702-13. [DOI: 10.1089/hum.2018.146] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 5.7] [Reference Citation Analysis]
31 Li Y, Meng Q, Yang M, Liu D, Hou X, Tang L, Wang X, Lyu Y, Chen X, Liu K, Yu AM, Zuo Z, Bi H. Current trends in drug metabolism and pharmacokinetics. Acta Pharm Sin B 2019;9:1113-44. [PMID: 31867160 DOI: 10.1016/j.apsb.2019.10.001] [Cited by in Crossref: 58] [Cited by in F6Publishing: 45] [Article Influence: 19.3] [Reference Citation Analysis]
32 Zhang Y, Pu Y, Wang J, Li Z, Wang H. Research progress regarding the role of long non-coding RNAs in osteosarcoma. Oncol Lett 2020;20:2606-12. [PMID: 32782578 DOI: 10.3892/ol.2020.11807] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
33 Kun-Peng Z, Chun-Lin Z, Xiao-Long M, Lei Z. Fibronectin-1 modulated by the long noncoding RNA OIP5-AS1/miR-200b-3p axis contributes to doxorubicin resistance of osteosarcoma cells. J Cell Physiol 2019;234:6927-39. [PMID: 30204936 DOI: 10.1002/jcp.27435] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 6.0] [Reference Citation Analysis]
34 James AR, Schroeder MP, Neumann M, Bastian L, Eckert C, Gökbuget N, Tanchez JO, Schlee C, Isaakidis K, Schwartz S, Burmeister T, von Stackelberg A, Rieger MA, Göllner S, Horstman M, Schrappe M, Kirschner-Schwabe R, Brüggemann M, Müller-Tidow C, Serve H, Akalin A, Baldus CD. Long non-coding RNAs defining major subtypes of B cell precursor acute lymphoblastic leukemia. J Hematol Oncol 2019;12:8. [PMID: 30642353 DOI: 10.1186/s13045-018-0692-3] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 6.0] [Reference Citation Analysis]
35 Hattinger CM, Patrizio MP, Fantoni L, Casotti C, Riganti C, Serra M. Drug Resistance in Osteosarcoma: Emerging Biomarkers, Therapeutic Targets and Treatment Strategies. Cancers (Basel) 2021;13:2878. [PMID: 34207685 DOI: 10.3390/cancers13122878] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
36 Pereira-Silva M, Alvarez-Lorenzo C, Concheiro A, Santos AC, Veiga F, Figueiras A. Nanomedicine in osteosarcoma therapy: Micelleplexes for delivery of nucleic acids and drugs toward osteosarcoma-targeted therapies. Eur J Pharm Biopharm 2020;148:88-106. [PMID: 31958514 DOI: 10.1016/j.ejpb.2019.10.013] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
37 Zhu KP, Zhang CL, Ma XL, Hu JP, Cai T, Zhang L. Analyzing the Interactions of mRNAs and ncRNAs to Predict Competing Endogenous RNA Networks in Osteosarcoma Chemo-Resistance. Mol Ther 2019;27:518-30. [PMID: 30692017 DOI: 10.1016/j.ymthe.2019.01.001] [Cited by in Crossref: 60] [Cited by in F6Publishing: 62] [Article Influence: 20.0] [Reference Citation Analysis]
38 Wang W, Luo P, Guo W, Shi Y, Xu D, Zheng H, Jia L. LncRNA SNHG20 knockdown suppresses the osteosarcoma tumorigenesis through the mitochondrial apoptosis pathway by miR-139/RUNX2 axis. Biochem Biophys Res Commun 2018;503:1927-33. [PMID: 30072099 DOI: 10.1016/j.bbrc.2018.07.137] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 5.5] [Reference Citation Analysis]
39 Zhou Q, Hou Z, Zuo S, Zhou X, Feng Y, Sun Y, Yuan X. LUCAT1 promotes colorectal cancer tumorigenesis by targeting the ribosomal protein L40-MDM2-p53 pathway through binding with UBA52. Cancer Sci 2019;110:1194-207. [PMID: 30690837 DOI: 10.1111/cas.13951] [Cited by in Crossref: 34] [Cited by in F6Publishing: 39] [Article Influence: 11.3] [Reference Citation Analysis]
40 Wang Y, Wang Y, Qin Z, Cai S, Yu L, Hu H, Zeng S. The role of non-coding RNAs in ABC transporters regulation and their clinical implications of multidrug resistance in cancer. Expert Opin Drug Metab Toxicol 2021;17:291-306. [PMID: 33544643 DOI: 10.1080/17425255.2021.1887139] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
41 Hu Y, Yang Q, Wang L, Wang S, Sun F, Xu D, Jiang J. Knockdown of the oncogene lncRNA NEAT1 restores the availability of miR-34c and improves the sensitivity to cisplatin in osteosarcoma. Biosci Rep 2018;38:BSR20180375. [PMID: 29654165 DOI: 10.1042/BSR20180375] [Cited by in Crossref: 35] [Cited by in F6Publishing: 20] [Article Influence: 8.8] [Reference Citation Analysis]
42 Wang H, Chi CH, Zhang Y, Shi B, Jia R, Wang BJ. Effects of histone deacetylase inhibitors on ATP-binding cassette transporters in lung cancer A549 and colorectal cancer HCT116 cells. Oncol Lett 2019;18:63-71. [PMID: 31289473 DOI: 10.3892/ol.2019.10319] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
43 Selvestrel D, Lucafò M, Pugnetti L, Pagarin S, Moressa V, Pastore S, Taddio A, Stocco G, Decorti G. Responses of patients with juvenile idiopathic arthritis to methotrexate: a genomic outlook. Expert Rev Clin Immunol 2021;:1-12. [PMID: 34392756 DOI: 10.1080/1744666X.2021.1968833] [Reference Citation Analysis]
44 Hu H, Yang L, Li L, Zeng C. Long non-coding RNA KCNQ1OT1 modulates oxaliplatin resistance in hepatocellular carcinoma through miR-7-5p/ ABCC1 axis. Biochem Biophys Res Commun. 2018;503:2400-2406. [PMID: 29966655 DOI: 10.1016/j.bbrc.2018.06.168] [Cited by in Crossref: 35] [Cited by in F6Publishing: 38] [Article Influence: 8.8] [Reference Citation Analysis]
45 Su M, Xiao Y, Ma J, Cao D, Zhou Y, Wang H, Liao Q, Wang W. Long non-coding RNAs in esophageal cancer: molecular mechanisms, functions, and potential applications. J Hematol Oncol 2018;11:118. [PMID: 30223861 DOI: 10.1186/s13045-018-0663-8] [Cited by in Crossref: 24] [Cited by in F6Publishing: 30] [Article Influence: 6.0] [Reference Citation Analysis]
46 Ghafouri-Fard S, Shirvani-Farsani Z, Hussen BM, Taheri M. The critical roles of lncRNAs in the development of osteosarcoma. Biomed Pharmacother 2021;135:111217. [PMID: 33433358 DOI: 10.1016/j.biopha.2021.111217] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
47 Haider T, Pandey V, Banjare N, Gupta PN, Soni V. Drug resistance in cancer: mechanisms and tackling strategies. Pharmacol Rep 2020;72:1125-51. [PMID: 32700248 DOI: 10.1007/s43440-020-00138-7] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
48 Ma Y, Bu D, Long J, Chai W, Dong J. LncRNA DSCAM‐AS1 acts as a sponge of miR‐137 to enhance Tamoxifen resistance in breast cancer. J Cell Physiol 2018;234:2880-94. [DOI: 10.1002/jcp.27105] [Cited by in Crossref: 35] [Cited by in F6Publishing: 34] [Article Influence: 8.8] [Reference Citation Analysis]
49 Kun-Peng Z, Xiao-Long M, Chun-Lin Z. Overexpressed circPVT1, a potential new circular RNA biomarker, contributes to doxorubicin and cisplatin resistance of osteosarcoma cells by regulating ABCB1. Int J Biol Sci 2018;14:321-30. [PMID: 29559849 DOI: 10.7150/ijbs.24360] [Cited by in Crossref: 136] [Cited by in F6Publishing: 140] [Article Influence: 34.0] [Reference Citation Analysis]
50 Shen Q, Xu Z, Xu S. Long non‑coding RNA LUCAT1 contributes to cisplatin resistance by regulating the miR‑514a‑3p/ULK1 axis in human non‑small cell lung cancer. Int J Oncol 2020;57:967-79. [PMID: 32945379 DOI: 10.3892/ijo.2020.5106] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
51 Kong D, Li C, Yang Q, wei B, Wang L, Peng C. Long noncoding RNA LSINCT5 acts as an oncogene via increasing EZH2-induced inhibition of APC expression in osteosarcoma. Biochemical and Biophysical Research Communications 2018;507:193-7. [DOI: 10.1016/j.bbrc.2018.11.005] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 2.5] [Reference Citation Analysis]
52 Jiang W, Xia J, Xie S, Zou R, Pan S, Wang Z, Assaraf YG, Zhu X. Long non-coding RNAs as a determinant of cancer drug resistance: Towards the overcoming of chemoresistance via modulation of lncRNAs. Drug Resistance Updates 2020;50:100683. [DOI: 10.1016/j.drup.2020.100683] [Cited by in Crossref: 34] [Cited by in F6Publishing: 33] [Article Influence: 17.0] [Reference Citation Analysis]
53 Dai J, Xu L, Hu X, Han G, Jiang H, Sun H, Zhu G, Tang X. Long noncoding RNA OIP5-AS1 accelerates CDK14 expression to promote osteosarcoma tumorigenesis via targeting miR-223. Biomedicine & Pharmacotherapy 2018;106:1441-7. [DOI: 10.1016/j.biopha.2018.07.109] [Cited by in Crossref: 37] [Cited by in F6Publishing: 35] [Article Influence: 9.3] [Reference Citation Analysis]
54 Zheng L, Hu N, Zhou X. TCF3-activated LINC00152 exerts oncogenic role in osteosarcoma through regulating miR-1182/CDK14 axis. Pathology - Research and Practice 2019;215:373-80. [DOI: 10.1016/j.prp.2018.12.031] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
55 Zhang B, Dong Y, Zhao Z. LncRNA MEG8 regulates vascular smooth muscle cell proliferation, migration and apoptosis by targeting PPARα. Biochem Biophys Res Commun 2019;510:171-6. [PMID: 30670309 DOI: 10.1016/j.bbrc.2019.01.074] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 5.7] [Reference Citation Analysis]
56 Soghli N, Qujeq D, Yousefi T, Soghli N. The regulatory functions of circular RNAs in osteosarcoma. Genomics 2020;112:2845-56. [DOI: 10.1016/j.ygeno.2020.03.024] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 7.0] [Reference Citation Analysis]
57 Viera GM, Salomao KB, de Sousa GR, Baroni M, Delsin LEA, Pezuk JA, Brassesco MS. miRNA signatures in childhood sarcomas and their clinical implications. Clin Transl Oncol 2019;21:1583-623. [PMID: 30949930 DOI: 10.1007/s12094-019-02104-z] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
58 Pang B, Wang Q, Ning S, Wu J, Zhang X, Chen Y, Xu S. Landscape of tumor suppressor long noncoding RNAs in breast cancer. J Exp Clin Cancer Res 2019;38:79. [PMID: 30764831 DOI: 10.1186/s13046-019-1096-0] [Cited by in Crossref: 18] [Cited by in F6Publishing: 21] [Article Influence: 6.0] [Reference Citation Analysis]
59 Li Y, Zou J, Li B, Du J. Anticancer effects of melatonin via regulating lncRNA JPX-Wnt/β-catenin signalling pathway in human osteosarcoma cells. J Cell Mol Med 2021;25:9543-56. [PMID: 34547170 DOI: 10.1111/jcmm.16894] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
60 Li YL, Wang XM, Qiao GD, Zhang S, Wang J, Cong YZ, Zhu SG. Up-regulated lnc-lung cancer associated transcript 1 enhances cell migration and invasion in breast cancer progression. Biochem Biophys Res Commun 2020;521:271-8. [PMID: 31635802 DOI: 10.1016/j.bbrc.2019.08.040] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
61 Xing C, Sun SG, Yue ZQ, Bai F. Role of lncRNA LUCAT1 in cancer. Biomed Pharmacother 2021;134:111158. [PMID: 33360049 DOI: 10.1016/j.biopha.2020.111158] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
62 Zhao W, Shan B, He D, Cheng Y, Li B, Zhang C, Duan C. Recent Progress in Characterizing Long Noncoding RNAs in Cancer Drug Resistance. J Cancer 2019;10:6693-702. [PMID: 31777598 DOI: 10.7150/jca.30877] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 5.0] [Reference Citation Analysis]
63 Smolle MA, Pichler M. The Role of Long Non-Coding RNAs in Osteosarcoma. Noncoding RNA 2018;4:E7. [PMID: 29657304 DOI: 10.3390/ncrna4010007] [Cited by in Crossref: 20] [Cited by in F6Publishing: 30] [Article Influence: 5.0] [Reference Citation Analysis]
64 Li W, Jin X, Zhao Y, Dai J, Cai Y. Long noncoding RNA GAS6-AS2 sponges microRNA-493, thereby enhancing the malignant characteristics of breast cancer cells via upregulation of FUT4. Pathol Res Pract 2020;216:152772. [PMID: 31839366 DOI: 10.1016/j.prp.2019.152772] [Reference Citation Analysis]
65 Sheng G, Gao Y, Yang Y, Wu H. Osteosarcoma and Metastasis. Front Oncol 2021;11:780264. [PMID: 34956899 DOI: 10.3389/fonc.2021.780264] [Reference Citation Analysis]
66 Lin Z, Xie X, Lu S, Liu T. Noncoding RNAs in osteosarcoma: Implications for drug resistance. Cancer Lett 2021;504:91-103. [PMID: 33587978 DOI: 10.1016/j.canlet.2021.02.007] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
67 Zhang L, Yang ST, Wang C, Zhang LC, Zhang X, Li FC, Wang SY, Ma K. Circle RNA circCSPP1 promotes human osteosarcoma cell proliferation and increases glucose metabolism by suppressing miR-200c maturation. Hum Exp Toxicol 2022;41:9603271221097364. [PMID: 35713481 DOI: 10.1177/09603271221097364] [Reference Citation Analysis]
68 Guo Y, Zhang H, Xie D, Hu X, Song R, Zhu L. Non-coding RNA NEAT1/miR-214-3p contribute to doxorubicin resistance of urothelial bladder cancer preliminary through the Wnt/β-catenin pathway. Cancer Manag Res 2018;10:4371-80. [PMID: 30349370 DOI: 10.2147/CMAR.S171126] [Cited by in Crossref: 15] [Cited by in F6Publishing: 7] [Article Influence: 3.8] [Reference Citation Analysis]
69 Yu W, Min D, Lin F, Zheng S, Tang L, He A, Hu H, Shen Z. SKA1 induces de novo MTX-resistance in osteosarcoma through inhibiting FPGS transcription. FEBS J 2019;286:2399-414. [PMID: 30851225 DOI: 10.1111/febs.14808] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
70 Chen B, Dong D, Yao Q, Zou Y, Hu W. A novel prognostic cancer-related lncRNA signature in papillary renal cell carcinoma. Cancer Cell Int 2021;21:545. [PMID: 34663322 DOI: 10.1186/s12935-021-02247-6] [Reference Citation Analysis]
71 Xu L, Wei B, Hui H, Sun Y, Liu Y, Yu X, Dai J. Positive feedback loop of lncRNA LINC01296/miR-598/Twist1 promotes non-small cell lung cancer tumorigenesis. J Cell Physiol 2019;234:4563-71. [PMID: 30240003 DOI: 10.1002/jcp.27235] [Cited by in Crossref: 15] [Cited by in F6Publishing: 20] [Article Influence: 3.8] [Reference Citation Analysis]
72 Gu Z, Hou Z, Zheng L, Wang X, Wu L, Zhang C. Long noncoding RNA LINC00858 promotes osteosarcoma through regulating miR-139-CDK14 axis. Biochem Biophys Res Commun 2018;503:1134-40. [PMID: 29944887 DOI: 10.1016/j.bbrc.2018.06.131] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 5.8] [Reference Citation Analysis]
73 Zhou Y, Sun W, Qin Z, Guo S, Kang Y, Zeng S, Yu L. LncRNA regulation: New frontiers in epigenetic solutions to drug chemoresistance. Biochem Pharmacol 2021;189:114228. [PMID: 32976832 DOI: 10.1016/j.bcp.2020.114228] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
74 Byun HJ, Yoon JH, Lee SK. LUCAT1 Epigenetically Downregulates the Tumor Suppressor Genes CXXC4 and SFRP2 in Gastric Cancer. Yonsei Med J 2020;61:923-34. [PMID: 33107235 DOI: 10.3349/ymj.2020.61.11.923] [Cited by in F6Publishing: 1] [Reference Citation Analysis]